Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy
EC-Cap-SC
1 other identifier
interventional
561
2 countries
6
Brief Summary
Comparison of Endocuff-assisted, Cap-assisted and Standard colonoscopy for assessment of the adenoma detection rate (ADR)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2015
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2015
CompletedFirst Posted
Study publicly available on registry
January 6, 2015
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedFebruary 12, 2019
February 1, 2019
4 years
January 2, 2015
February 10, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adenoma detection rate
Proportion of patients having at least one adenoma
1 year
Polyp detection rate
Proportion of patients having at least one adenoma
1 year
Secondary Outcomes (8)
Bowel preparation result
one day
Coecum intubation rate
one year
Ileum intubation rate
one year
Coecum intubation time
one day
withdrawal time
one day
- +3 more secondary outcomes
Study Arms (3)
Arc Endocuff (AEC 110, 120, 130, 140)
ACTIVE COMPARATOREndocuff-assisted colonoscopy Colonoscopy with the Endocuff attached at the distal tip of the scope
Cap
ACTIVE COMPARATORCap-assisted colonoscopy Colonoscopy with the transparent Cap attached at the distal tip of the scope
Standard Colonoscope
ACTIVE COMPARATORStandard colonoscopy without any additional device
Interventions
Eligibility Criteria
You may qualify if:
- Colonoscopy independent from indication
- Age ≥ 18
- Patient is able to provide informed consent for the procedure
You may not qualify if:
- Inflammatory Bowel Disease stenosis
- Pregnant of nursing patient
- Acute diverticulitis
- Active Inflammatory Bowel Disease
- Age ≤ 18
- Coagulation disorder (INR\>1.4 , Thrombocytes \< 50000/µl)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
University of Muenster
Münster, North Rhine-Westphalia, 48149, Germany
University Medical Center Göttingen
Göttingen, 37075, Germany
HELIOS St. Marienberg Klinik Helmstedt
Helmstedt, Germany
HELIOS Albert-Schweitzer-Klinik
Northeim, 37154, Germany
HELIOS Medical Center Siegburg
Siegburg, Germany
Wroclaw Medical University
Wroclaw, 50-556, Poland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tobias Meister, Prof. Dr.med.
Helios Albert-Schweitzer-Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med. Tobias Meister
Study Record Dates
First Submitted
January 2, 2015
First Posted
January 6, 2015
Study Start
February 1, 2015
Primary Completion
February 1, 2019
Study Completion
February 1, 2019
Last Updated
February 12, 2019
Record last verified: 2019-02